Home / Medications / Releuko

Releuko Patient assistance program

Is your Releuko medication too expensive? Start receiving your medication for only $49 per month.*

Complete a free online enrollment application to find out if you’re eligible to pay only $49 per month for your Releuko medication with our help.

Get Started Now
  • NiceRx Benefit
    Secure: Your personal and medical information is safe with us
  • NiceRx Benefit
    Convenient: Your medication is delivered straight to your door
  • NiceRx Benefit
    Ongoing refills: Your medication is refilled automatically
  • NiceRx Benefit
    Secure: Your personal and medical information is safe with us
  • NiceRx Benefit
    Convenient: We manage the whole process and we’re here to assist you
  • NiceRx Benefit
    Ongoing refills: We request your medication refills on your behalf

NiceRx works with your healthcare provider to help you access affordable medications directly from U.S. pharmaceutical companies.

An introduction to NiceRx

Play video (01:52)
  • An introduction to NiceRx
    (01:52)
  • Next steps after qualifying
    (00:38)
  • Uploading documents and billing
    (00:50)
  • SSN & billing information
    (00:33)
  • Medication delivery time
    (00:41)

How it works

  • Apply Online

    Get started by filling out the online enrollment application to find out if you are eligible.

  • Qualification

    NiceRx verifies your eligibility for medication assistance and notifies you if you are qualified. The pharmaceutical company provides your medication for free and you only pay our service fee.

  • Upload Documents

    You may be required to submit further information and documents required by the pharmaceutical company which can be securely uploaded online.

  • Application Created

    Your application is created and sent to your doctor for signature. At this stage, you will be billed $49 and will not be billed again until you receive your first medication delivery.

  • Receive Medication

    Your application is sent to the pharmaceutical company. You will be billed again once you receive your medication. We handle the entire ordering process including requesting ongoing refills.

Medically reviewed by  Jamie Winn, PharmD

Your monthly Releuko cost savings if eligible

The Releuko patient assistance program can provide your medication for free. We simply charge $49 per month for each medication to cover the cost of our services. With NiceRx, you will only pay $49 to obtain your Releuko, regardless of the retail price.

Am I eligible for the Releuko patient assistance program?

To find out if you are eligible for Releuko assistance you can apply online using our enrollment application. Each pharmaceutical company sets its eligibility criteria, and we will review your application individually to determine if you may be eligible. The three main factors to consider are:

  • I am a permanent, legal resident of the United States or Puerto Rico
  • I am uninsured or my insurance doesn’t cover my medication
  • I meet certain income eligibility requirements

How do I apply for the Releuko patient assistance program?

Our application process aims to make it as easy as possible to apply for the Releuko patient assistance program. The first step is to complete our online enrollment application. We will ask you for details about your healthcare provider, your insurance plan, and your household income as this information is required by the pharmaceutical companies. We may be able to help you apply for other patient assistance programs too, so be sure to tell us about any medications you are taking as well as Releuko.

NiceRx will review your application and determine whether you may be eligible for Releuko assistance. If so, we will handle the full enrollment process for you and prepare all required documents for your healthcare provider to sign. Once you are successfully enrolled in the Releuko patient assistance program, we will help you manage your prescription refills by requesting refills on your behalf throughout your enrollment period. At the end of your enrollment period we will contact you for updated information and seek to re-enroll you so you can continue to access affordable Releuko.

Is NiceRx a Releuko coupon provider?

NiceRx is a service provider that helps eligible individuals access the Releuko patient assistance program. We do not offer trial offers or free Releuko samples. When obtaining your medication through NiceRx, you will only pay $49 a month per medication. This will likely save you more money than if you were to use Releuko coupons, discount cards, or Releuko copay cards.

Can NiceRx help me get Releuko cheaper if I have insurance?

NiceRx may be able to help you if your insurance company will not pay for your Releuko medication. We may also be able to help if you have a high copay or coinsurance responsibility. Whether you have insurance or not, apply online using our enrollment application to find out more.

How much does Releuko cost without insurance?

Releuko prices without insurance will vary depending on how much you buy. Prices will also vary by retailer. As a guide, Releuko injectable solution (ayow 300 mcg/0.5 mL) typically costs $2,400 for 5 milliliters.

How much does Releuko cost with insurance?

The copay for Releuko will vary by the terms of your healthcare plan. To find out what you might need to pay for Releuko with insurance, your insurance provider or pharmacist will be able to help you calculate the copay costs with your current insurance.

What is Releuko?

Releuko is an FDA (U.S. Food and Drug Administration) approved medication manufactured by Kashiv Biosciences and Amneal Pharmaceuticals. It is a leukocyte (white blood cell) growth factor used to reduce the:

  • Incidence of infection‚ as seen by febrile neutropenia‚ in patients with non-myeloid malignancies receiving myelosuppressive anti-cancer treatments related to a significant incidence of severe neutropenia with fever
  • Time to neutrophil recovery and the duration of fever, following induction or consolidation chemotherapy therapy of patients with acute myeloid leukemia (AML)
  • Duration of neutropenia and neutropenia-related clinical sequelae‚ e.g.‚ febrile neutropenia, in patients with non-myeloid malignancies receiving myeloablative chemotherapy followed by bone marrow transplantation (BMT)
  • Incidence and duration of sequelae of severe neutropenia‚ (fever‚ infections‚ oropharyngeal ulcers) in patients with congenital neutropenia‚ cyclic neutropenia‚ or idiopathic neutropenia

Releuko has FDA approval as a biosimilar Neupogen. Biosimilar means that the biological product is approved based on data showing that it is highly similar to an FDA-approved biological product, known as the reference product and that there are no clinical differences between the biosimilar product and the reference product.

What doses of Releuko are available?

Releuko is available in injection form, in the following doses: 300 mcg/mL in a single-dose vial, 480 mcg/1.6 mL in a single-dose vial, or in injection form in a prefilled syringe, in the following doses: 300 mcg/0.5 mL in a single-dose prefilled syringe, or 480 mcg/0.8 mL in a single-dose prefilled syringe.

Releuko is administered via subcutaneous injection

Please see the full prescribing information and always speak with your healthcare provider for medical advice about any changes to your dose so they can monitor and evaluate your condition.

Releuko active ingredients

Releuko contains filgrastim-ayow as the active ingredient.

Releuko side effects

The most common side effects of Releuko in clinical trials include:

  • Pyrexia
  • Pain
  • Rash
  • Cough, dyspnea
  • Epistaxis
  • With severe chronic neutropenia – anemia, diarrhea, hypoesthesia, alopecia

In rare instances, Releuko can cause more serious side effects. These can include:

  • Fatal splenic rupture
  • Acute respiratory distress syndrome (ARDS) – monitor patients who develop fever and lung infiltrates or respiratory distress
  • Serious allergic reactions, including anaphylaxis
  • Fatal sickle cell crises
  • Glomerulonephritis
  • Myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML)
  • Thrombocytopenia

Your doctor will assess the benefits of using Releuko against your risk of side effects. Patients are encouraged to report negative side effects or adverse reactions of Releuko to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Releuko drug interactions

Other drugs may interact with Releuko, including prescription drugs and over-the-counter medicines, vitamins, and herbal products. Tell your health care provider about all of your medications including any supplements you are taking.

Releuko contraindications

You should not use Releuko if you:

  • Have a history of serious allergic reactions to human granulocyte colony-stimulating factors (G-CSF) such as filgrastim-ayow or pegfilgrastim products
  • Are allergic to any of the other ingredients in Releuko
  • Are pregnant or are planning to become pregnant

Talk to your doctor before using Releuko if you:

  • Are taking any of the medications that could interact with Releuko
  • Are breastfeeding or are planning to breastfeed

Releuko generic

Releuko is the trademark brand name for filgrastim-ayow manufactured by Kashiv Biosciences and Amneal Pharmaceuticals. A generic version of filgrastim-ayow is not available. Generic drugs are generally cheaper than brand-name drugs, but you can still find Releuko savings through NiceRx.

Related medications

*Qualifying persons may obtain medications directly from patient assistance programs without any out-of-pocket cost (or for less than $49 per medication). However, our monthly flat rate of just $49 per medication spares you the hassle of tracking the different programs and filling out all the required paperwork for each program. Subject to medication availability.

Enrollees enjoy a full-service solution, as NiceRx assists them and their physicians with the entire process. We prepare all required documents for the physician to sign, help enrollees manage all prescription refills, monitor eligibility criteria, and maintain enrollment.

**If you do not receive medications because you were determined to be ineligible for the prescription assistance by the applicable pharmaceutical companies and you have a letter of denial, we will refund any fees you paid toward medications for which you did not qualify to receive prescription assistance (“Refund”).

To receive a refund, you must send the letter of denial to us by fax to 888-517-7444, or by e-mail to [email protected] within 30 days of your receipt of such letter. The Refund is your sole and exclusive remedy for any fees you may wish to dispute.

The content on this website is intended for information purposes only. It does not constitute medical advice. The information on this website should not be relied upon and is not a substitute for professional medical advice. You should always speak to your doctor regarding the risks and benefits of any treatment.